Robert Watson – Partner, patent attorney, chemistry at Mewburn Ellis
Robert handles patent work in the Mewburn Ellis chemistry team. His work is focused in the pharmaceutical chemistry sector, where he applies his over 25 years’ experience in providing commercially focussed strategic advice. His work spans the product and IP lifecycle, including invention capture, drafting, global prosecution, opposition, and freedom-to-operate.
Andrew Williams – Partner, patent attorney, chemistry at Mewburn Ellis
Andrew plays a leading role in Mewburn Ellis’s growing ‘Speciality Pharma’ team. He focuses particularly on supplementary protection certificates (SPCs), patent term extensions (PTEs), regulatory protection, and patent-regulatory listings, as well as commercial and strategic aspects to consider for a medicinal product throughout its development and post-launch phases. This work has involved written and oral proceedings with the European Medicines Agency (EMA) in relation to the EU’s Orphan Drug Exclusivity regime.